NCT00249223 – Risperidone Depot (Microspheres) vs. Risperidone Tablets – a Non-inferiority, Efficacy Trial in Subjects With Schizophrenia Posted on March 8, 2018 by tsuperadmin -
NCT00044681 – A Study to Evaluate the Efficacy, Safety and Maintenance Effect of Risperidone Augmentation of SSRI Monotherapy in Young and Older Adult Patients With Unipolar Treatment-Resistant Depression Posted on August 24, 2017 by tsuperadmin -
An open-label, long-term study of risperidone for the treatment of behavioral disturbances in patients with dementia Posted on May 9, 2016 by tsuperadmin -
The safety and efficacy of risperidone 8 mg qd and 4 mg qd compared to placebo in the treatment of schizophrenia Posted on March 31, 2016 by tsuperadmin -
NCT00253123 – A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia Posted on March 31, 2016 by tsuperadmin -
The efficacy and safety of flexible dose ranges of risperidone vs. Placebo or divalproex sodium in the treatment of manic or mixed episodes associated with bipolar 1 disorder Posted on March 31, 2016 by tsuperadmin -
NCT00257075 – The Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Episodes Associated With Bipolar I Disorder Posted on March 31, 2016 by tsuperadmin -
NCT00034762 – Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer’s Disease Posted on March 31, 2016 by tsuperadmin -
A double-blind, placebo-controlled study of risperidone in children and adolescents with autistic disorder Posted on March 31, 2016 by tsuperadmin -
NCT00253136 – Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia Posted on March 31, 2016 by tsuperadmin -
The YODA Project